Botox 100unit Injection

Manufacturer ALLERGAN Active Ingredient OnabotulinumtoxinA Injection(oh nuh BOT yoo lin num TOKS in aye) Pronunciation Oh-nuh-BOT-yoo-lin-num-TOKS-in-A
WARNING: Severe effects of this drug may affect parts of the body away from where it was injected. Signs can happen hours to weeks after the injection. Swallowing and breathing problems can be deadly. The risk is greatest in children with certain muscle problems (spasticity) but can happen in all people. Swallowing problems may last for several months. Call your doctor right away if you have blurred eyesight or see double, change in voice, drooping eyelids, or loss of strength or weakness all over the body. Call your doctor right away if you are not able to control your bladder or have trouble breathing, speaking, or swallowing. @ COMMON USES: It is used to lower underarm sweating. It is used to prevent migraine headaches.It is used to treat muscle problems around the eye.It is used to treat muscle problems that lead to spasms.It is used to treat neck pain and abnormal placement of the head due to a certain health problem called cervical dystonia.It is used to treat loss of bladder control in certain people.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Neuromuscular blocker; Anti-spasmodic; Migraine prophylaxis; Bladder dysfunction agent; Cosmetic agent
đŸ§Ŧ
Pharmacologic Class
Botulinum Toxin Type A
🤰
Pregnancy Category
Category C
✅
FDA Approved
Dec 1989
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Botox is a medicine made from a purified protein that temporarily relaxes muscles or reduces nerve signals. It's used for various medical conditions like chronic migraines, muscle spasms, excessive sweating, and bladder problems, as well as for cosmetic purposes like reducing wrinkles. It works by blocking signals from nerves to muscles or glands, causing them to relax or reduce activity.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all the information provided. Adhere to the dosage and administration guidelines closely. This medication is administered via injection.

For proper storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to store this medication at home.

If you miss a dose, contact your doctor to schedule an office visit to discuss the next steps.
💡

Lifestyle & Tips

  • Avoid rubbing or massaging the injection site for at least 24 hours after treatment, as this could cause the medicine to spread to unintended areas.
  • Remain upright for at least 4 hours after injections, especially for cosmetic treatments.
  • Report any unusual or severe symptoms immediately to your doctor, especially difficulty swallowing, breathing, or speaking, or generalized weakness.
  • Understand that the effects are temporary and will wear off over several months, requiring repeat injections for continued benefit.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on indication and patient response. Dosing is in units and specific to injection sites.

Condition-Specific Dosing:

Glabellar Lines: 4 units per site, 5 sites (20 units total), repeat every 3-4 months.
Chronic Migraine: 155 units total, administered intramuscularly into 7 specific head/neck muscle areas (31 injection sites), repeat every 12 weeks.
Upper Limb Spasticity: Total dose up to 400 units, divided among affected muscles. Max 400 units per 3 months.
Lower Limb Spasticity: Total dose up to 400 units, divided among affected muscles. Max 400 units per 3 months.
Primary Axillary Hyperhidrosis: 50 units per axilla, administered intradermally. Repeat as needed, typically every 7 months.
Overactive Bladder (OAB) with Incontinence: 100 units total, administered via cystoscopy into the detrusor muscle. Repeat no sooner than every 12 weeks.
Neurogenic Detrusor Overactivity (NDO): 200 units total, administered via cystoscopy into the detrusor muscle. Repeat no sooner than every 12 weeks.
Cervical Dystonia: Initial dose 1.25 units to 5 units per injection site, total dose typically 100-300 units, divided among affected muscles. Max 300 units per 3 months.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Approved for lower limb spasticity in pediatric patients 2 years of age and older (up to 8 units/kg, max 300 units per treatment session).
Adolescent: Approved for chronic migraine in patients 18 years of age and older. Approved for upper/lower limb spasticity in patients 2 years of age and older. Dosing for spasticity is weight-based.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended.
Moderate: No specific dose adjustment recommended.
Severe: No specific dose adjustment recommended.
Dialysis: No specific dose adjustment recommended. Use with caution due to limited data.

Hepatic Impairment:

Mild: No specific dose adjustment recommended.
Moderate: No specific dose adjustment recommended.
Severe: No specific dose adjustment recommended.

Pharmacology

đŸ”Ŧ

Mechanism of Action

OnabotulinumtoxinA acts at the neuromuscular junction to inhibit the release of acetylcholine from presynaptic motor neurons. This inhibition occurs through the cleavage of SNAP-25, a protein essential for the successful docking and release of acetylcholine vesicles. The resulting chemical denervation produces localized muscle paralysis or reduction in glandular activity (e.g., sweat glands, bladder detrusor muscle). The effect is reversible as new nerve terminals sprout and re-establish connection with the muscle endplate.
📊

Pharmacokinetics

Absorption:

Bioavailability: Minimal systemic absorption following therapeutic intramuscular or intradermal injection.
Tmax: Not applicable for systemic absorption; local effect onset is days.
FoodEffect: Not applicable.

Distribution:

Vd: Not well-defined due to localized action and minimal systemic distribution.
ProteinBinding: Not well-defined due to localized action.
CnssPenetration: No (does not cross the blood-brain barrier).

Elimination:

HalfLife: Not precisely determined for the active toxin due to localized action and irreversible binding. The duration of clinical effect is typically 3-6 months.
Clearance: Not precisely determined due to localized action.
ExcretionRoute: Not applicable systemically; degraded locally.
Unchanged: Not applicable systemically.
âąī¸

Pharmacodynamics

OnsetOfAction: Typically 24-72 hours, but full effect may take 1-2 weeks.
PeakEffect: Approximately 1-2 weeks after injection.
DurationOfAction: Typically 3-6 months, depending on the indication and individual patient response.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Distant Spread of Toxin Effect: Postmarketing reports indicate that the effects of BOTOX and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, symptoms consistent with distant spread of toxin have been reported.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Pain while urinating
+ Mouth sores
+ Wounds that won't heal
Changes in vision, eye pain, or severe eye irritation
Sensitivity to bright lights
Drooping eyebrows
Dizziness or fainting
Seizures
Heart attack or abnormal heart rhythms, which can be fatal. Seek immediate medical attention if you experience:
+ Chest pain or pressure
+ Abnormal heartbeat
For patients taking this medication for loss of bladder control:
+ Signs of a urinary tract infection (UTI), such as:
- Blood in the urine
- Burning or pain while urinating
- Frequent or urgent need to urinate
- Fever
- Lower abdominal or pelvic pain
+ Difficulty urinating

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Irritation at the injection site
Neck pain
Arm or leg pain
Headache
Decreased blinking
Dry eyes
Dry mouth
Cough
Flu-like symptoms
Back pain
Runny nose
Fatigue or weakness
Mild fever
Upset stomach
Drowsiness
* Common cold symptoms

This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Difficulty swallowing, speaking, or breathing (can be life-threatening)
  • Generalized muscle weakness
  • Double vision, blurred vision, or drooping eyelids
  • Loss of bladder control (if not the treated condition)
  • Hoarseness or other voice changes
  • Severe allergic reactions (e.g., rash, hives, itching, swelling of the face/lips/tongue/throat, dizziness, feeling faint, shortness of breath, wheezing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

To ensure safe treatment, inform your doctor about the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction you experienced, such as symptoms and signs.
Presence of an infection at the injection site, as this may affect the administration of the medication.
If you have a neuromuscular disease, such as myasthenia gravis, Lambert-Eaton syndrome, or amyotrophic lateral sclerosis (ALS), as these conditions may interact with the medication.

For Patients with Loss of Bladder Control:

If you have a current urinary tract infection, as this may need to be treated before starting the medication.
If you experience difficulty urinating or have trouble emptying your bladder, as the medication may worsen these conditions.
If you are unable to empty your bladder on your own, as this may require special consideration when taking the medication.

It is essential to note that this list is not exhaustive, and you should discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health issues. Never start, stop, or change the dose of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

Before taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

If you have received a botulinum toxin product within the last 3 to 4 months, discuss this with your doctor before starting treatment. Additionally, be cautious when driving or performing tasks that require alertness and clear vision until you understand how this medication affects you.

It is crucial to note that when this drug has been used for unapproved purposes, severe side effects such as extreme weakness and swallowing difficulties have occurred, sometimes with fatal outcomes. These severe side effects have happened even in individuals with pre-existing swallowing problems or other health issues. Consult your doctor to discuss the potential risks.

As this medication is derived from human plasma, a component of blood, there is a risk of transmitting viruses that can cause disease. Although the drug undergoes rigorous screening, testing, and treatment to minimize the risk of infection, it is essential to discuss this with your doctor.

If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor to weigh the benefits and risks of this medication to both you and your baby.

Special Considerations for Loss of Bladder Control

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
🆘

Overdose Information

Overdose Symptoms:

  • Generalized muscle weakness
  • Ptosis (drooping eyelids)
  • Diplopia (double vision)
  • Dysphagia (difficulty swallowing)
  • Dysphonia (difficulty speaking)
  • Dysarthria (slurred speech)
  • Respiratory distress or failure (due to paralysis of respiratory muscles)

What to Do:

Seek immediate emergency medical attention. Supportive care, including respiratory support (e.g., mechanical ventilation), may be required. Call 1-800-222-1222 (Poison Control) or your local emergency services.

Drug Interactions

🔴

Major Interactions

  • Aminoglycoside antibiotics (e.g., gentamicin, tobramycin)
  • Spectinomycin
  • Other agents interfering with neuromuscular transmission (e.g., curare-like non-depolarizing blockers, succinylcholine)
🟡

Moderate Interactions

  • Muscle relaxants (e.g., baclofen, tizanidine)
  • Anticholinergic agents (e.g., atropine, scopolamine)
  • Calcium channel blockers (e.g., verapamil, diltiazem)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history and physical examination

Rationale: To assess suitability for treatment, identify pre-existing neuromuscular disorders, and determine appropriate injection sites and dosing.

Timing: Prior to initial treatment.

Muscle function assessment (e.g., spasticity scales, range of motion)

Rationale: To establish baseline severity and guide injection strategy for therapeutic indications.

Timing: Prior to initial treatment.

Allergy history

Rationale: To identify potential hypersensitivity to botulinum toxin or excipients.

Timing: Prior to initial treatment.

📊

Routine Monitoring

Clinical response and efficacy

Frequency: At follow-up visits (e.g., 2-4 weeks post-injection, then prior to subsequent injections)

Target: Improvement in symptoms (e.g., reduced spasticity, decreased migraine frequency, improved bladder control, reduced wrinkles)

Action Threshold: Lack of desired effect may indicate need for dose adjustment or alternative treatment.

Adverse effects (e.g., localized weakness, dysphagia, breathing difficulties)

Frequency: At each follow-up visit and patient education on self-monitoring.

Target: Absence or minimal, manageable adverse effects.

Action Threshold: Presence of severe or persistent adverse effects, especially signs of distant toxin spread, requires immediate medical attention and may necessitate discontinuation or dose reduction.

Muscle strength and function

Frequency: At follow-up visits, especially for spasticity or dystonia.

Target: Desired therapeutic effect without excessive weakness.

Action Threshold: Excessive weakness may indicate over-dosing or inappropriate injection site.

đŸ‘ī¸

Symptom Monitoring

  • Difficulty swallowing (dysphagia)
  • Difficulty breathing (dyspnea)
  • Speech changes (dysphonia)
  • Generalized muscle weakness
  • Vision changes (e.g., blurred vision, diplopia, ptosis)
  • Loss of bladder control (if not the target indication)
  • Severe allergic reactions (e.g., rash, itching, swelling, dizziness, shortness of breath)

Special Patient Groups

🤰

Pregnancy

Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Potential risk to fetus cannot be ruled out. Animal studies have shown developmental toxicity at doses higher than clinical doses.
Second Trimester: Potential risk to fetus cannot be ruled out.
Third Trimester: Potential risk to fetus cannot be ruled out.
🤱

Lactation

It is not known whether OnabotulinumtoxinA is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in a breastfed infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 - Moderate risk. Due to the large molecular weight, systemic absorption is minimal, and transfer into breast milk is unlikely to be significant. However, potential for systemic effects in the infant cannot be entirely excluded. Monitor infant for signs of muscle weakness or feeding difficulties.
đŸ‘ļ

Pediatric Use

Approved for specific indications in pediatric patients (e.g., lower limb spasticity in patients 2 years and older). Dosing is weight-based for spasticity. The risk of distant spread of toxin effect is probably greatest in children treated for spasticity.

👴

Geriatric Use

No overall differences in safety or effectiveness were observed between elderly subjects and younger subjects in clinical trials, but greater sensitivity of some older individuals cannot be ruled out. Use with caution, generally starting at the lower end of the dosing range.

Clinical Information

💎

Clinical Pearls

  • Botox unitage is not interchangeable with other botulinum toxin products (e.g., Dysport, Xeomin, Jeuveau, Daxxify). Each product has its own unique potency and dosing guidelines.
  • Reconstitution of Botox requires sterile, preservative-free 0.9% Sodium Chloride Injection. The amount of diluent varies based on the desired concentration for the specific indication.
  • Proper injection technique, including accurate muscle identification and precise dosing, is crucial to minimize adverse effects and maximize therapeutic benefit.
  • Patients should be thoroughly educated on the signs and symptoms of distant toxin spread and instructed to seek immediate medical attention if they occur.
  • Anticoagulant use (including antiplatelet agents) should be carefully considered prior to injection due to increased risk of bruising or bleeding at the injection site.
  • Patients with pre-existing neuromuscular disorders (e.g., Myasthenia Gravis, Lambert-Eaton Syndrome, ALS) are at increased risk of clinically significant systemic effects from typical doses of Botox and should generally avoid its use.
🔄

Alternative Therapies

  • Other botulinum toxin products (e.g., AbobotulinumtoxinA [Dysport], IncobotulinumtoxinA [Xeomin], PrabotulinumtoxinA [Jeuveau], DaxibotulinumtoxinA [Daxxify])
  • For spasticity: Oral muscle relaxants (e.g., baclofen, tizanidine, dantrolene), physical therapy, occupational therapy, surgery.
  • For chronic migraine: CGRP inhibitors (e.g., erenumab, fremanezumab, galcanezumab), oral prophylactic medications (e.g., topiramate, propranolol, amitriptyline).
  • For overactive bladder: Anticholinergic medications (e.g., oxybutynin, tolterodine), beta-3 agonists (e.g., mirabegron), sacral neuromodulation.
  • For primary axillary hyperhidrosis: Topical antiperspirants (e.g., aluminum chloride), oral anticholinergics, iontophoresis, surgery.
  • For cervical dystonia: Oral medications (e.g., anticholinergics, benzodiazepines), physical therapy, surgery.
💰

Cost & Coverage

Average Cost: Highly variable, typically $600 - $1200 per 100-unit vial per 100-unit vial
Insurance Coverage: Coverage varies significantly. Often covered by medical insurance for FDA-approved therapeutic indications (e.g., chronic migraine, spasticity, overactive bladder, cervical dystonia, hyperhidrosis) but typically not for cosmetic uses. Prior authorization is almost always required for therapeutic uses.
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective use of your medication, never share your prescription with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Properly dispose of unused or expired medications by checking with your pharmacist for guidance on the best disposal method. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain, as this can harm the environment. Many communities offer drug take-back programs, which provide a safe and responsible way to dispose of unwanted medications.

It is crucial to carefully read the Medication Guide, a patient fact sheet provided with this medication, and review it again each time your prescription is refilled. If you have any questions or concerns about your medication, consult with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred, as this will help healthcare professionals provide the best possible care.